Literature DB >> 102422

Acquisition of angiogenic capacity and neoplastic transformation in the rat mammary gland.

A Maiorana, P M Gullino.   

Abstract

The ability to induce formation of new vessels was tested in fragments of rat mammary tissue transplanted onto the rabbit iris and observed through the transparent cornea. Virgin, pregnant, and lactating glands showed an angiogenic capacity in about 5% of implants. In contrast mammary carcinomas induced angiogenesis in 75 to 100% of implants. Fragments of mammary gland previously treated with 7,12-dimethylbenz[alpha]anthracene of N-nitrosomethylurea but without histological evidence of neoplastic transformation showed an angiogenic response in about 5% of implants. The same low angiogenic response was detected in primary hyperplastic alveolar nodules. However, angiogenesis was observed 2 to 3 times more frequently in implants from hyperplastic outgrowths that acquired of continuous transplantability and showed a high degree of neoplastic transformation. These data on the rat mammary gland confirm previous findings on mouse mammary gland, indicating that: (a) neoplastic epithelium has a higher angiogenic capacity than does normal epithelium; and (b) hyperplastic epithelium at high risk of undergoing neoplastic transformation induces angiogenesis more frequently than does hyperplastic epithelium with low tumor potential.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102422

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  Atlas and histologic classification of tumors of the rat mammary gland.

Authors:  J Russo; I H Russo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

3.  Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.

Authors:  B B Moore; D A Arenberg; K Stoy; T Morgan; C L Addison; S B Morris; M Glass; C Wilke; Y Y Xue; S Sitterding; S L Kunkel; M D Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 4.  Significance of rat mammary tumors for human risk assessment.

Authors:  Jose Russo
Journal:  Toxicol Pathol       Date:  2014-05-28       Impact factor: 1.902

5.  Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder.

Authors:  G W Chodak; C Haudenschild; R F Gittes; J Folkman
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

6.  The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenz(alpha)anthracene-treated LEW/Mai rats.

Authors:  D M Purnell
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

Review 7.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

8.  Stimulation by a low-molecular-weight angiogenic factor of capillary endothelial cells in culture.

Authors:  A M Schor; S L Schor; J B Weiss; R A Brown; S Kumar; P Phillips
Journal:  Br J Cancer       Date:  1980-05       Impact factor: 7.640

9.  Reducing the hypoxic fraction of a tumour model by growth in low glucose.

Authors:  L Hlatky; R K Sachs; C S Ring
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.

Authors:  D R Smith; P J Polverini; S L Kunkel; M B Orringer; R I Whyte; M D Burdick; C A Wilke; R M Strieter
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.